Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

RISE Is Ready for MIPS

From the College  |  February 16, 2017

Participation in a QCDR, such as RISE, allows you to collect 30 points immediately through two population management activities:

  1. Use of a QCDR to generate regular performance feedback that summarizes local practice patterns and treatment outcomes, including those of vulnerable populations. Weight (high): 20 points.
  2. Participation in a QCDR; clinical data registry; or other registry run by government agencies, such as the FDA, or private entities, such as a hospital or medical or surgical society; and using the data for quality improvement (e.g., comparative analysis across specific patient populations for adverse outcomes after an outpatient surgical procedure and corrective steps to address an adverse outcome). Weight (medium): 10 points.

For a full list of CPIAs, visit the CMS website.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Advancing Care Information
Satisfying ACI requirements will largely depend on the individual practice’s EHR system.

You must complete one of two options for ACI: 1) ACI Objectives and Measures or 2) 2017 ACI Transition Objectives and Measures. The length of time that your practice engaged in Meaningful Use will determine which of the two pathways you will take to satisfy this category.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

You can report the ACI Objectives and Measures if you have:

  • Technology certified to the 2015 edition; or
  • A combination of technologies from the 2014 and 2015 editions that support these measures.

You can report the 2017 ACI Transition Objectives and Measures if you have:

  • Technology certified to the 2015 edition;
  • Technology certified to the 2014 edition; or
  • A combination of technologies from 2014 and 2015 editions.

By participating in a QCDR, such as RISE, you are eligible for a 5% bonus in this category.

If you need help identifying your EHR edition or you would like to learn more about this category, follow this link.

Pick Your Pace for 2017
The final rule for MACRA calls for a transition year so that providers may become accustomed to the new payment program. There are four options that rheumatologists can pick from to begin the transition into MIPS:

  1. Non-Participation: This results in a 4% negative payment adjustment.
  2. Test Data Submission: Providers will avoid a negative payment adjustment, but will not be eligible for a bonus. This also requires one measure on one patient for one visit, or you can submit one improvement activity.
  3. Partial Data Submission: Submit 90 days of data, and you may earn a neutral or positive payment adjustment. For partial reporting, you must submit the required data for all three required categories in 2017:
    (a) Quality: Six measures, including an outcome/high-priority measure;
    (b) ACI: Four to five measures, depending on the option applicable to your EHR; and
    (c) Clinical Practice Improvement Activities: Providers may choose two highly weighted or four medium-weighted activities.
  4. Full Data Submission: Submit a full year of 2017 data to Medicare, and you may earn a positive payment adjustment. The reporting requirements are the same as for partial data submission (3a–c above), but for the entire year.

Want to Learn More?
If you are interested in joining RISE or have questions about the payment program in 2017, contact ACR staff at [email protected]. If you would like to learn more about the new Quality Payment Program, visit the Quality Payment Program information section on the CMS’s website.

Page: 1 2 3 | Single Page
Share: 

Filed under:From the CollegePractice SupportProfessional TopicsResearch Rheum Tagged with:MACRAMedicare Access and CHIP Reauthorization ActMerit-based incentive payment systemMIPSRheumatology Informatics System for Effectiveness (RISE) RegistryRISE

Related Articles

    Providers Using RISE Have Advantage with 2017 MIPS Reporting

    March 15, 2018

    Hundreds of rheumatology providers across the country are finalizing submissions for the first year of reporting under the Merit-Based Incentive Payment System (MIPS). According to a presentation at the 2017 ACR/ARHP Annual Meeting in San Diego, providers that participate in and submit through the Rheumatology Informatics System for Effectiveness (RISE) Registry are poised to perform…

    RISE Readiness for MIPS in 2018

    February 1, 2018

    In 2018, all providers will have to submit an entire year’s worth of their quality measure data to the CMS. After 2017, the transition year, the requirements and performance thresholds begin to increase. The CMS is still heavily incentivizing participation in a Qualified Clinical Data Registry (QCDR), such as the RISE registry, for reporting in…

    RISE Registry Helps ACR Members Successfully Navigate MIPS

    April 26, 2018

    Time certainly flies, and 2018 marks the second year that rheumatologists who see Medicare patients are operating under the new Quality Payment Program (QPP) created by the Medicare Access & CHIP Reauthorization Act (MACRA). MACRA repealed the Fee-for-Service model under the Sustainable Growth Rate (SGR) formula and transitioned Medicare reimbursement to a system more overtly…

    2023 Medicare Physician Fee Schedule Final Rule for Quality Payment Program Published

    January 6, 2023

    The ACR highlights essential policy and reporting changes to the Quality Payment Program for performance year 2023 and beyond. Key changes include policies regarding the development of new MIPS Value Pathways and refinement of subgroup participation.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences